Amarin Corp Plcuk (AMRN) Shareholder's Equity Growth (5y) (2015 - 2026)

Amarin Corp Plcuk (AMRN) Shareholder's Equity Growth (5y) (2015 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Amarin Corp Plcuk 6.77 Bn 6.59 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.67%
Dec 31, 2025 -6.05%
Sep 30, 2025 -5.45%
Jun 30, 2025 -5.06%
Mar 31, 2025 -4.16%
Dec 31, 2024 -4.38%
Sep 30, 2024 -2.27%
Jun 30, 2024 29.92%
Mar 31, 2024 31.12%
Dec 31, 2023 29.37%
Sep 30, 2023 65.65%
Jun 30, 2023 69.98%
Mar 31, 2023 106.01%
Dec 31, 2022 61.96%
Sep 30, 2022 71.30%
Jun 30, 2022 76.16%
Mar 31, 2022 89.26%
Dec 31, 2021 137.55%
Sep 30, 2021 111.51%
Jun 30, 2021 42.74%